Focus and Scope

International Journal of Bioprinting is an international journal covering the technology, science and clinical application of the broadly defined field of Bioprinting. Bioprinting is defined as the use of 3D printing technology with materials that incorporate viable living cells or biological elements to produce tissue or biotechnological products.

We are interested in the scientific topics spanning all stages of bioprinting process from concept creation to fabrication and beyond. Knowledge generated in these researches must be related to bioprinting.

The journal publishes original research articles on basic and applied research as well as associated social implications of this research. The journal also publishes brief commentaries and reviews. Articles focusing on the practical applications of 3D-printed products are similarly welcome.

Examples of relevant topics include but are not limited to:

Information technologies and basic research

  • Medical scanning and imaging for printable format
  • Data security and validation in medical additive manufacturing
  • Logistic management in bioprinting
  • Mass customization design methodology or platform technology
  • Blueprint for organ printing
  • Automated algorithm for 3D modelling of bioprintable files
  • Research models (e.g. cancer, pre-surgical evaluation, etc.)

Materials and formulation

  • New material and method of preparation
  • Hybrid and composite material system
  • Evaluation technologies for bioprinting process and bioprinted product
  • Biomimetic and bioinspired design and material system
  • Interaction of processing and materials
  • Post-processing of bioprinted medical constructs

Cell source and biotechnology for additive manufacturing

  • Cell source research
  • Large-scale or high throughput cell culture techniques
  • Tissue spheroid research (modelling, analysis, measurement, biological observation, characterization)
  • Interaction of cell-material

3D Bioprinting technologies

  • Bioprinting technologies or 3D printing techniques for direct manipulation of cells and biological elements
  • New printing systems or new printing methodology
  • Optimization methodology 

New design and fabrication paradigm

  • Hybrid approach in medical additive manufacturing
  • Information technologies and software in
  • Architectural design
  • Real time and non-invasive monitoring techniques
  • Maturation techniques of printed construct
  • Bioreactor for printed construct

Applied research purpose & evaluation of 3D printed products

  • Implants and prosthetics
  • Bioprinting
  • Biological tissue model for toxicology testing, drug delivery, drug production-related
  • Scaffold for tissue engineering
  • Regenerative medicine
  • Medical imaging purposes (e.g. 3D-printed probes)
  • Bionic organ
  • Organ printing
  • Personalized drug
  • Biomodels for surgical training and planning
  • Exoskeleton
  • Further optimisation/advantages/limitations
  • Education

Associated social implications

  • Ethics
  • Economic relationships and shifts
  • Policies and regulation
  • Intellectual property (IP-copyright, design protection, patents, and trademarks), licensing
  • Business (e.g. chain supply, management)
  • Environmental impact
  • Community sentiments to 3D-printed products (e.g. healthcare providers, users, etc.)

 

Section Policies

Original Articles

Original Articles are scientific articles based on original, basic and applied research and/or analysis.

This manuscript type typically has 5 tables and figures in total, approximately 40 references, and 7,000 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Articles

A Review Article summarizes and highlights recent developments and current/future trends of the field.

This manuscript type typically has 5 tables and figures in total, approximately 70 references, and 7,000 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Communications

Short Communications are short articles that present original and significant findings on a particular problem or novel findings that are anticipated to have significant impact.

The length of a Short Communication, including the Abstract and References, should not exceed 4,000 words. The article should contain Abstract (not more than 150 words), Background, Materials and Method, Results, Discussion, Conclusion and References, and contain no more than 5 figures and/or tables. Typically, this manuscript type has 15 references.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Perspective Articles

Perspective Articles contain the author's personal opinions on a subject/topic. Unlike Reviews, Perspective articles may cover a more specific, narrow part of the field. However, these are still required to uphold the spirit of academia to be objective as well as aim to initiate or further discussions and novel experimental procedures in the field.

This manuscript type typically has 5 tables and figures in total, approximately 70 references, and 7,000 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Commentaries

This type of article contains unsolicited commentaries or analysis from the reader(s) targeting specific published articles in the journal.

This manuscript type typically has 3 tables and figures in total, approximately 20 references, and 3,500 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Clinical Case Studies

A Clinical Case Study presents the details and results from the clinical application of bioprinted products or equivalents on patient cases, and highlights specific instances of interesting phenomena. Submissions will be evaluated on a case-by-case basis.

This manuscript type typically has 5 tables and figures in total, approximately 20 references, and 3,000 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Methods

Methods articles present new or improved version of experimental methods, tests or procedures pertaining to the field of bioprinting.

This manuscript type typically has 10 tables and figures in total, approximately 30 references, and 5,000 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letters to the Editor-in-Chief/Authors

Comments from reader(s) about individual articles. These letters must be constructive and contribute to the development of individual articles published or the entire journal. Letters containing new ideas, supporting data or data criticizing the article may be subjected to peer-review (determined on a case-by-case basis by the journal's editorial team) and published in the online publication but not in the printed version. Authors should specify the intended recipient of the letters i.e. editor-in-chief or stating the specific author(s) name.
This manuscript type typically has 1,800 words (exclusive of reference list)

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Reports

A Report summarizes the execution of a collaborative research program that is directly related to the advancement of bioprinting. Submissions are usually solicited by the editors.

This manuscript type typically has 5 tables and figure in total, 20 references, and 5,000 words (inclusive of Abstract and References).

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Position Papers

A Position Paper reflects the official opinion of an organization (e.g. government body, funding agency, etc.).

This manuscript type typically has 2 tables and figure in total, not more than 15 references, and 3,500 words (inclusive of References). An Abstract is not required in a Position Paper.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Editorials

An Editorial is a solicited, concise commentary that highlights prominent topics in particular issue. Commonly, the Editorials are the official opinions of the editors of the journal or special issue.

An Editorial should not exceed 1,000 words (inclusive of References). Typically, an Abstract is not required and only one figure/table is allowed.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Book Reviews

Book Reviews provide an overview of new publications (books) from the area of bioprinting. Brief summary, focus, argumentation and impact of the book should be provided.

A Book Review is typically of the length of 400-500 words. No Abstract, References, figures and tables are required.

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Extended Conference Papers

An Extended Conference Paper is the conference paper version of an original research article that presents the new findings and in-depth discussion of a certain topic.

The manuscripts that do not have relevance to the Focus and Scope of International Journal of Bioprinting will be rejected.

The requirements for Extended Conference Papers are as follows:

- The Extended Conference Paper must have at least 30% new material and include a citation to the conference paper. In addition to the 30% new material which is acquired through additional experimentation, analyses and proposal of new ideas or theories, the original content that can be found in the conference paper must be paraphrased, i.e. rewriting the sentences or changing the sentence structure. The 30% new material may also include the clarifications in response to questions raised during the presentation at the conference.

- The Extended Conference Paper must have a new title and a new abstract that are different from the corresponding title in the conference paper. Nevertheless, the new title and new abstract must retain the ‘motivation, methods and conclusions’ of the paper presented at the conference presentation. More data in the form of tables and figures should be added. The results should be discussed in-depth with more examples and explanations. In this regard, more references will be needed.

- The conference paper must be cited.

- A PDF copy of the conference paper must be submitted along with the submission of the Extended Conference Paper.

- The format and style of an Extended Conference Paper are similar to the ones of an Original Article. Refer to the specific requirements of the Original Articles.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Erratum

An erratum refers to the notification of a significant error made by the journal that affects the scholarly record or the scientific integrity of a published article. An erratum is always accompanied by Publisher Correction of the error introduced to the article. The corrections will not be made directly in the already-published articles. Authors who notice an error in their published articles should contact the editors at editor@whioce.com.

All publisher-introduced changes will be highlighted to the author for proofreading before final publication of the erratum.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Corrigendum

A corrigendum refers to the notification of an important error made by the author(s) that affects the scholarly record or the scientific integrity of a published article. A corrigendum is always accompanied by Author Correction of the error introduced to the article. The corrections will not be made directly in the already-published articles.

If certain errors are found, authors should contact the editors at editor@whioce.com, who will evaluate the impact of the errors and decide on the appropriate course of action. Any corrections to a paper are published at the sole discretion of the editors.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Addendum

An addendum refers to the notification of additional information about a published article. An addendum will only be published only if the editors decide that the additional information is essential to the reader’s understanding of a significant part of the published article. The additional information should be construed as description, information, details or data that aid the readers to better understand the published works and should not significantly or substantially alter the original ideas of the works.

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Recommended by editorial board

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All manuscripts submitted to International Journal of Bioprinting will follow the following procedure:

  • Initial submission is reviewed by in-house editors to ensure adherence to journal policies and for double-blind review
  • Editor-in-chief decides on the manuscript to be sent out for review process and assigns the manuscript to one of the editors according to the particular topic.
  • Editor assigns reviewers from inside the editorial board or outside depending on the topic.
  • After evaluations by the reviewers have been received, the editor-in-chief makes one of the following recommendations: accept, minor revision, major revision, reject and resubmit, and reject.
  • If decision is minor revision, the authors have 7 days to resubmit the revised manuscript.
  • If decision is major revision, the authors have 14 days to resubmit the revised manuscript.
  • Upon resubmission, the same procedure is applied as for the initial submission.
  • Authors may appeal for a rejected submission. Appeal requests must be made in writing to editor@whioce.com with detailed reasons for the appeal and point by point responses to the reviewers remarks. Decisions on appeals are final without exception.
  • For all manuscripts accepted for publication, the peer review process will be deemed to be completed. The manuscript will proceed to be copyedited, layout edited and proofread before being published online.

Note: You may suggest up to four academically qualified reviewers for consideration. Please insert the current contact details of the reviewer and state the reason(s) for recommendation under the "Comments for the Editor" section. However, please take note that the Editorial team strives to ensure the peer review process is fair and unbiased and hence, there is no guarantee that a recommended reviewer will be approached to perform the peer review.

 

Publication Frequency

Quarterly

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Publishing Ethics

International Journal of Bioprinting requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by Committee on Publication Ethics (COPE) in compliance with the information and guidelines on handling publishing ethics allegations as described in the Publishing Ethics Resource Kit (PERK).

The journal strictly adheres to the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals  Editors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).

The journal editors take all possible misconducts seriously. The Editors, authors or readers can forward their concerns to the journal if they find out that the description in a submitted article may constitute an academic fraud, research misconduct or publication malpractice. The concerns or complaints on the possible allegations submitted to the journal will be dealt with promptly and appropriately according to the procedure set out in the COPE flowchart on complaints and in PERK. The complainant may direct all inquiries and correspondence to the Publisher at editor@whioce.com.

International Journal of Bioprinting adopts a zero-tolerance policy concerning any academic misconducts and ethical violations in research and publication regardless of the severity of these issues. The violations include plagiarism, falsification of research, data fabrication, submitting manuscripts of others as one’s own, submission of same manuscript to different publication venues at the same time and breached intellectual property rights. In cases of suspected misconduct and ethical violation, a panel will be formed to investigate the allegation. If the allegation is supported by evidence, the submitted manuscript in question will be declined for consideration in the journal and all authors will be informed in this regard. A retraction initiated by authors or by the journal is required to take place if the paper has already been published, and the retraction will be made public. Authors of the work in question will receive the Panel’s Decision via email and all appeals regarding the decision will have to be made to the Publisher at editor@whioce.com within 28 days of the decision date.

 

Editorial Policies

Authors should read the “Author Guidelines” before making a submission, and make sure that the manuscripts were written in accordance to the style and specifications of the journal’s policy.

All manuscripts submitted to International Journal of Bioprinting are subject to rigorous peer review. Prior to peer review process, the manuscripts will be screened for acceptable English language, novelty and relevance to the Focus and Scope of the journal.

Any manuscripts submitted to International Journal of Bioprinting will be treated as confidential materials. The manuscripts will not be disclosed to anyone except individuals such as editorial staff, reviewers and editors who participate in the initial screening, review, processing and preparation of the manuscript for publication (if accepted).

A manuscript would not be considered if it has been published or is currently under consideration for publication in any other journals. In the cover letter, authors must state that neither the manuscript nor any significant part of it is under consideration for publication elsewhere or has appeared elsewhere in a manner that could be construed as a prior or duplication of the same work. The authors are required to notify the editorial team if the findings and data in their submissions have been presented in conferences.

 

Preprint Policy

Authors are permitted to post their non-peer-reviewed original research manuscripts to community preprint servers such as bioRxiv, medRxiv, and PeerJ Preprint before or in parallel with the formal submission to the International Journal of Bioprinting. During submission, authors are obliged to declare in the cover letter if the corresponding preprint version of their submission has been deposited on a preprint server, and provide any associated accession numbers or DOIs.

Nonetheless, authors are not allowed to post any versions of articles that have been revised as a result of peer review, accepted for publication or published in the journal on a preprint server. The manuscript whose corresponding preprint version has been indexed (e.g. in MEDLINE or PubMed) will not be considered.

This policy applies to original research papers only. International Journal of Bioprinting reserves the right not to consider for publication or publish material that has been formally published in digital media that shall not be construed as preprint servers.

We encourage formal citation of preprints in the reference list, where appropriate.

 

Authorship

Authorship should be limited to people who have contributed substantially to the work. Authors must indicate their specific contributions to the published work. This information should be listed in the manuscript under the section ‘Author Contribution’. Examples of contributions include: designed research, performed research, contributed new reagents or analytic tools, analyzed data, wrote the paper.

For more information on submission’s format, please refer to the ‘Author Guidelines’ link accessible from the ‘About’ button at the top row of this page.

The corresponding author should be clearly indicated for all manuscripts submitted. A maximum of two corresponding authors are allowed for the responsibilities associated. The corresponding author(s) is responsible for:

  • Obtaining permission from all the authors mentioned in the manuscript
  • Ensuring adherence to all editorial and submission policies and for any communications and actions that may be necessary after publication
  • Including written permission from the authors of the work concerned for any mention of any unpublished material included in the manuscript, e.g. data from manuscripts-in-press, personal communication, or work in preparation.

 

Changes to Authorship

The authors should carefully check the list and order of authors before submitting their manuscript. The Editorial Office considers the authorship list is definitive by the time the original submission is received.

Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript is accepted for publication. The corresponding author should provide the reasons for the change in authorship list and the proof of written confirmation from all authors (including the existing authors, author(s) to be added and/or removed) agreeing with such change, to the Editorial Office.

The requests for authorship changes need to be approved by the Editorial Office before any changes can be made.

 

Conflict of Interest

At the time of submission, the authors must declare the conflicts or competing interests with any financial body or funding agency that might influence the results or interpretation of their submitted works. The disclosure should also include all sources of revenue paid (or promised to be paid) directly to authors or their institution on your behalf over the 36 months before submission of the relevant work. Authors who have nothing to declare are encouraged to add "No conflict of interest was reported by all authors" in this section.

Authors will be requested to complete ICMJE form for Disclosure of Potential Conflict of Interest when they are invited to submit a revision. Failure to do return a completed form will result in a delay to editorial and peer review progress. If necessary, the initial disclosure statement provided by the authors will be subject to edits for grammar corrections by the editors. Failure to comply with the conflict of interest disclosure statement requirement may result in rejection of the submissions.

In addition, reviewers and editors must disclose any association that poses a conflict of interest in connection with the manuscript. Examples of such activities could include personal or work-related relationships, events, etc.

 

Plagiarism

The editorial team does not approve of any plagiarism attempts. iThenticate will be utilized at the editor’s discretion to verify the originality of submitted manuscripts. If plagiarism is detected during the review process the manuscript may be rejected pending the severity of plagiarism. Therefore, if a manuscript uses a text copied directly from another source, this text must be written in quotation marks and the original source must be cited.

 

Language

All articles must be written in English — preferably American English. SI units should be used. If you are not a native English speaker, you may want to utilize an external or Whioce Publishing’s optional professional language editing service before submitting the final version.

Whioce Publishing Pte Ltd offers its own professional editing services. By using this service, you can be sure that your English-language manuscript will be polished and ready for submission to your publication of choice at a very reasonable price. For further details about the Language Editing Services, please contact us at academic@whioce.com. Please note that utilizing a language editing service is not a guarantee of acceptance.

 

Human Research

If human subjects were used in the experiments, authors must identify the committee or organization (e.g. author’s Institutional Ethics Review Board) approving the experiments in the Methodology section of the manuscript, which should also detail ethics approval information such as the name of the granting committee or organization and the approval identifiers, i.e. reference numbers. International Journal of Bioprinting requires that authors provide a proof of research ethics or ethics statement along with the submission. In the case that ethics approval identifiers are not available, written approval from the granting committee or organization must be provided as confidential supplemental file.

In the manuscript, include a statement in the Methodology section confirming that the experiments were carried out in adherence to the ethical principles set out in the WMA Declaration of Helsinki and that informed consent was obtained from all human subjects. 

For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., oral or written) should be stated clearly as well.

The authors should inform the study participants of the purpose(s) of publication, the possible risks and benefits as a result of the experiment, and the patient's right to withhold or withdraw consent. Consent should be obtained from the parent(s) or legal guardian(s) if the study participant is a minor.

Authors are obliged to declare and clearly specify any restrictions on the availability or the use of human data in the manuscript.

Authors are encouraged to follow the CARE guidelines while reporting a clinical case that involves the use bioprinted construct on human subject. If the article reporting guidelines suggested by the International Journal of Bioprinting were not pertinent to your work, please look for and refer to the appropriate reporting standards as found on EQUATOR Network, which have been adopted by the field of the works or which apply to their study design.

 

Randomized Clinical Trials

A clinical trial is defined as any research study that prospectively assigns human subjects to one or more medical or health-related interventions to study the cause-and-effect association between a medical or health-related intervention and a health outcome. In the context of bioprinting, the medical or health-related interventions refer to the use of biological structures produced from tissue engineering or bioprinting in the treatments of diseases and injuries.

International Journal of Bioprinting requires, as a condition of consideration for publication, registration of the trials in a publicly accessible registry approved by the WHO or ICMJE at or before the onset of patient enrolment. Compliance with our policies is required at submission in order for a manuscript to proceed. Authors are encouraged to review the CONSORT Statement before submitting reports of randomized clinical trials.

At manuscript submission, authors must provide the following:

  • CONSORT checklist (as Supplementary File)
  • CONSORT flow diagram (as Figure 1) that demonstrates the progress of patient recruitment, enrolment, randomization, withdrawal and completion through the trial
  • Trial protocol (as Supplementary File)

The manuscript file must include the following information:

  • Registration details (in the Methods section)
  • Clinical trial registration number (at the end of the abstract)
  • A detailed description of the randomization procedure
  • An explanation of any deviation from the trial protocol
  • Description about obtaining informed consent from participants
  • Disclosure of statistical methods or participants that not indicated in the CONSORT checklist and flow diagram

Reports of randomized clinical trials that are not in adherence to the CONSORT Statements may be returned to the authors for revision before any formal review begins. International Journal of Bioprinting reserves the right to ask for a blank sample copy of any forms used in the trial.

 

Patient Anonymity and Privacy

Human subjects have a right to privacy that should not be violated without informed consent. Identifying information or patient identifiers, including patient names, initials, date of birth, contacts, medical record numbers, hospital numbers, and geographical location, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Efforts must be made by the authors to at least mask or conceal any identifying information of the patients that appear in writing or within photograph.

Authors are obliged to explain to the patient if revealing the patient’s identity cannot be fully avoided, e.g. an image of an identifiable body part like the face has to be published in the report. The relevant identifying information to be published, e.g. the image, must be shown to the patient, and consent for publication taken for the use of that information in the publication. If the patient dies, then consent must be obtained from next of kin or legal representative. Authors may consider using our sample Consent Form for Publication in the International Journal of BioprintingInternational Journal of Bioprinting shall consider author version of consent form for publication if all the essential items as shown in our sample consent form were included.

All submissions will be checked for documentation of patient consent for publication and for any potentially identifying information. Submissions that include identifying patient information without appropriate patient consent will not be considered for publication.

Refer to ICMJE Privacy and Confidentiality guidelines for more information about patient anonymity and privacy.

 

Animal Research

For studies reporting experiments that involve testing on regulated animals (i.e. all live vertebrates and/or higher invertebrates), authors must identify the committee or organization (e.g. author’s Institutional Ethics Review Board) approving the experiments in the Methodology section of the manuscript, which should also detail ethics approval information such as the name of the granting committee or organization and the approval identifiers, i.e. reference numbers. For research conducted on non-regulated animals, a statement should be made as to why ethical approval was not required.

International Journal of Bioprinting requires that authors provide a proof of research ethics or ethics statement along with the submission. In the case that ethics approval identifiers are not available, written approval from the granting committee or organization must be provided as confidential supplementary file.

Authors are encouraged to follow the ARRIVE guidelines while reporting animal research. In the manuscripts, any additional guidelines for the care and use of laboratory animals that were used in the experiment should be indicated. Briefly, the authors should also include animal details (e.g. species, gender, age, weight), animal housing conditions and husbandry information, and relevant steps taken to ameliorate pain and suffering of the animals in the Methodology section.

Specifically, experiments on non-human primates must be performed in accordance with the recommendations set out in the Weatherall report (The Use of Non-Human Primates in Research).

 

Application of Cell Lines

To ensure research reproducibility, authors must declare what cell lines were used in their experiment and the source or origin of all cell lines utilized. It is advisable to provide information regarding the authentication of cell lines and testing for mycoplasma contamination.

Generation of de novo cell lines derived from human tissue must be approved by the relevant ethics committee (or author’s Institutional Ethics Review Board). Authors must identify the committee or organization (e.g. author’s Institutional Ethics Review Board) approving the experiments in the Methodology section of the manuscript, which should also detail ethics approval information such as the name of the granting committee or organization and the approval identifiers, i.e. reference numbers. International Journal of Bioprinting requires that authors provide a proof of research ethics or ethics statement along with the submission. In the case that ethics approval identifiers are not available, written approval from the granting committee or organization must be provided as confidential supplementary file. Authors must confirm that they obtained the consent from the donor or next of kin for deriving a cell line from the donor.

 

Policy Enforcement

All submissions describing human and/or animal research will be preliminarily examined by journal editors to ensure that the specific requirements set out in the journal policies and guidelines are met. Submissions that do not meet the requirements may be rejected.

International Journal of Bioprinting reserves the right to decline submissions that the editors believe the described works have not been conducted to the highest possible ethical standards, despite formal ethics approval has been obtained.

If ethical concerns arise or are discovered after publication, investigations will be organized. Any evidence pointing to substantial violations of ethical codes or oversight for the research may lead to a correction (e.g. erratum, corrigendum) or retraction of the paper. Authors’ institution, ethics committee or other appropriate body in relation to the potential ethical concerns may be contacted during the investigation.

 

Data Processing Policy

Authors are expected to have minimum amount of post-acquisition processing of data. In case of processing; alterations must be applied to the entire image (e.g., brightness, contrast, color balance). Any kind of alteration if being done has to be clearly stated in the figure legend and in Methods section.

Grouping of data (e.g., cropping of images of removal of lanes from gels and bolts) must be made apparent and should be explicitly indicated in the appropriate figure legends. Data comparisons should only be made from comparative experiments, and individual data should not be utilized across multiple figures. If inappropriate image/data manipulation is identified after publication, we reserve the right to ask for the original data and, if that is not satisfactory, to issue a correction or retract the paper, as appropriate.

 

Copyright and License

Copyright

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

 

License

NOTE: Starting from Volume 7 Issue 3 (2021), all articles published by International Journal of Bioprinting will be licensed under Creative Commons Attribution 4.0 International License (CC BY 4.0). In order to allow unrestricted reuse of article content and remove the barriers of mining article content for research, the new commercial CC BY 4.0 license will replace the default Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) that has been in use since the inception of the journal.
 
International Journal of Bioprinting publishes accepted manuscripts under Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors who submit their papers for publication by International Journal of Bioprinting agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source is properly cited, anyone may copy, redistribute, reuse and transform the content. 
 
Reuse of International Journal of Bioprinting article content
 
Anyone is free to reuse International Journal of Bioprinting article content licensed under CC BY 4.0 provided that proper attribution is given through citation of the original source.
 
To reuse International Journal of Bioprinting article content licensed under CC BY-NC 4.0 for commercial purposes (including republishing in journals or books), please seek written permission of the copyright owner, i.e. the authors. Upon obtaining the permission to reuse, you are required to adhere to the guidelines below for giving proper attribution of International Journal of Bioprinting article content:
(i) Cite the article in your final work (i.e. as one of the references); if possible, include the DOI of the article.
(ii) Depending on the style of the medium or journal where you will publish or produce your work, mention the last name of the first author (i.e. the copyright holder) and et al., year of publication, reference citation number (depending on journal’s requirement, and the type of the Creative Commons license used in the form of a statement and place it beneath the content you reuse from the article; see example below:
Adapted with permission from Lee, et al., 2018 [38]; licensed under Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0), https://creativecommons.org/licenses/by-nc/4.0/.
(iii) If you remix or modify the original work to create a derivative work, you should still attribute the original work and identify that changes have been made to it.
 
If you have any questions, please contact our editors at editor@whioce.com. 
 
Reuse of licensed material published in another journal or book (third-party content)
 
Authors are responsible in obtaining the appropriate permissions from the copyright owner, e.g. original publisher or authors, to reuse or republish any previously published text, figures, tables, Supplementary Information, etc., in an article of International Journal of Bioprinting licensed under a CC BY 4.0 license. The official and written proof of permission must be provided along with submission, and include in the cover letter a summary regarding the licensed materials that are reused in the paper (e.g. materials that require permission and those that do not if they were published under an unrestrictive licence). Upon obtaining the permission, authors should also give proper attribution as per the copyright owner’s style.
 
It is important to note that there is a range of Creative Commons licenses with terms that cater to different needs of copyright owners. In general, if the material was published under a CC BY license or another license that permits free and unrestricted use, the material may be reused in International Journal of Bioprinting paper as long as proper attribution is given by citing the original source. Another example is Creative Commons Attribution-NoDerivatives License (CC BY-ND) that allows redistribution of the content, even commercially, provided that the content is reused in its entirety. Nevertheless, contact the copyright owner if you have any questions about the license terms because the Editors of  International Journal of Bioprinting cannot give any legal advice regarding the rights to use third-party content.
 
Authors are not allowed to use any third-party content in the International Journal of Bioprinting paper if written permission to reuse is not obtained from the copyright owner. In the absence of official documentation granting permission to reuse third-party content or when concerns about copyright, license or permissions arise, the Editors of International Journal of Bioprinting reserves the right to remove any third-party content from any article, whether before or after publication. 

 

Submission Withdrawal Policy

In International Journal of Bioprinting, withdrawal of a submission refers to the removal of a new submission, a paper currently under peer-review, an accepted paper, or an Article in Press from the online submission system. Removal of a formally published article is known as retraction.

 

Author-initiated submission withdrawal

If authors change their mind and decide not to pursue publication of papers with the journal, they must write a letter addressed to our editors at editor@whioce.com, explaining the reason(s) of submission withdrawal. Consents of all co-authors must be obtained for author-initiated submission withdrawal. The decision to withdraw a submission would eventually rest with the editors, including the Editor-in-Chief.

It is relatively more difficult in withdrawing a paper that has been processed for peer-review or is under peer-review compared to withdrawing a new submission because the editors and reviewers have expended much time and energy in editorial process and manuscript evaluation, respectively. To withdraw a paper that has been processed for peer-review, authors should clearly argue their case on scientific reasons; only valid and sound reasons will be accepted. Once the approval of submission withdrawal is granted, the submission will be removed from the journal’s online submission system, and a confirmation email of submission withdrawal will be sent to the authors.

In general, the editors of International Journal of Bioprinting consider the following as *unethical and unreasonable reasons* of withdrawing a submission:

  • Unaware of the Article Processing Charge payable after paper acceptance (or reluctant to pay Article Processing Charge). Authors are advised to find out the publication fees associated with the journal before making a decision to submit. It is unethical to submit and proceed with the editorial process for a submission under consideration for publication if authors do not have plans of paying the Article Processing Charge upon acceptance.
  • Do not want to make all research data or findings available to the journal. Before a submission is made, authors are responsible to check whether the research data or findings presented in manuscript are compatible with their desired journal and/or type of submission they intend to make. There are no defined criteria as to how much data or findings should be published in a paper but it is our belief that bioprinting, just like other scientific, medical and technological principles, take sufficient data to make precise and accurate interpretation from experiments. Thus, it is in authors’ best interest to provide, present and publish all relevant data and findings.
  • Wanting to submit to a higher- or lower-impact journal. It’s the authors’ responsibility to vet the journal background before making a decision to submit. Making a submission to the journal is comparable to admitting that the quality and standard of the submission match with that of the journal.

In the event that authors insist to withdraw submission on unethical and unreasonable grounds (see the above-mentioned *unethical and unreasonable reasons*), they will be demanded to pay submission withdrawal fee that is charged at 30% of the Article Processing Charge. Authors should pay the fee within 4 weeks after the invoice has been issued. In the absence of payment, the names of these authors (corresponding authors and co-authors of a submission) will be blacklisted and banned from publishing with International Journal of Bioprinting in future until the payment is made. Once the payment of submission withdrawal fee is made, the submission will be removed from the journal’s online submission system, and a confirmation email of submission withdrawal will be sent to the authors.

 

Withdrawal of accepted paper and Article in Press

Submission withdrawal is also possible for accepted papers that have not been formally published, including the newly accepted papers and Articles in Press.

Withdrawal of accepted paper and Article in Press is usually editor-initiated. The reasons of withdrawing accepted papers and Articles in Press are similar to those of retracting a published article, i.e. academic misconducts and ethical violations in research and publication regardless of the severity of these issues. The misconducts and violations include plagiarism, falsification of research, data fabrication, submitting manuscripts of others as one’s own, submission of same manuscript to different publication venues at the same time and breached intellectual property rights. Once the suspected misconduct and ethical violation is brought to our attention, the editors will organize an investigation and authors are required to cooperate in the investigation; any accepted papers or Articles in Press subject to investigation at this stage will not be arranged for article production or finalization. A Panel will be organized to investigate the allegations. If the allegations are proven true with supporting evidence, the accepted paper or Article in Press will be marked for withdrawal, and a notification email regarding the Panel’s Decision will be sent to all authors of the work. Any appeals regarding the Panel’s Decision will have to be made to the Publisher within 14 days of the decision date. In the absence of an appeal from the authors within the 14 days, the submission will be removed from the journal’s online submission system, and a confirmation email of submission withdrawal will be sent to the authors.

Authors should note that any amounts of paid Article Processing Charge will not be refunded if their accepted papers or Articles in Press are withdrawn on the grounds of academic misconducts and ethical violations in research and publication.

 

Advertising Policy

All advertisements are subject to approval to the Publisher. Advertisements must comply with the relevant regulations in the country where the advertisements appear. For more inquiries, please send email to editor@whioce.com.

 

Indexing & Archiving

Indexing 

International Journal of Bioprinting (IJB) is indexed, cataloged and/or included by several world-class abstracting/indexing databases:

 

Archives

The contents of IJB are archived and preserved by PMC and Portico.

 

Frequently Asked Questions

(1) How do I find out if my manuscript is within the scope of this journal?

Answer: To establish whether your paper is suitable for this journal, please read Focus and Scope before submissions.

 

(2) How do I submit my manuscript to this journal?

Answer: Registration and login are required to submit manuscript online and to check the status of current submission.

 

(3) What type of file format can be submitted?

Answer: The submission file can be submitted in Microsoft Word document file format.

 

(4) Do I need to enclose my submission with a cover letter?

Answer: The cover letter is necessary for each submission. International Journal of Bioprinting has specific requirements for what should be included in a cover letter. Please refer to the Author Guidelines for more details. The cover letter will only be visible to the editor. Reviewers will not have access to the cover letter.

 

(5) Is it essential to suggest reviewers for my manuscript?

Answer: You can suggest up to four reviewers for your submission. However, the decision of whether to invite them lies with the Editor.

 

(6) Is there any publication fee charged for papers published in this journal?

Answer: Refer to the Publication Fees tab for more details.

 

Article Processing Charges (APC)

NOTE: International Journal of Bioprinting will incur an Article Processing Charge (APC) of US$ 2,500 for the acceptance and publication of an article submitted and accepted on or after July 1, 2021. The original APC rate of US$ 800 will still apply for the articles submitted before July 1, 2021.

International Journal of Bioprinting is an Open Access Journal under Whioce Publishing. All articles published in International Journal of Bioprinting are accessible electronically from the journal website without commencing any kind of payment. In order to mainatain open access and publishing quality, Article Processing Charge (APC) is applicable to authors to cover the cost incurred in processing the manuscripts. Such cost covers the peer-review, copy-editing, typesetting, publishing, content depositing and archiving processes. Those charges are applicable only to authors who have their manuscript successfully accepted after peer-review. Articles that do not require peer-review such as letters, editorials, book reviews, corrigenda, and addenda will be published free of charge.

Journal TitleAPC
International Journal of BioprintingUS$ 2,500

Whioce Publishing will continue to endorse the program of supporting authors from the low and lower middle income countries/regions by offering APC waivers. A range of discounts or waivers are offered to authors who are unable to pay the full amount of APC. Authors can write in to apply for a waiver and requests will be considered on a case-by-case basis, subject to the approval of the Editor-in-Chief and the Publisher.

If you are residing in one of the above-mentioned countries and need to apply for a waiver, please email our editorial department (editor@whioce.com) with the following information:
• Your name and institution with full address details
• Title of journal you wish to submit a manuscript to
• Reason for applying for a waiver
• Title of your paper
• Country of residence of all co-author

 

Disclaimer

International Journal of Bioprinting is not liable to the statements, perspectives, and opinions contained in the published articles. The appearance of advertisements in the journal shall not be construed as a warranty, endorsement, or approval of the products or services advertised and/or the safety thereof. International Journal of Bioprinting and the Publisher disclaim responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.